Chapter 1 - Inquiry into the provisions of the Industrial Chemicals Bill 2017 and related bills
[1]
House of Representatives Votes and Proceedings, No. 57, 1 June
2017, pp. 810–811.
[2]
The Hon. Dr David Gillespie MP, Assistant Minister for Health, House
of Representatives Hansard, 1 June 2017, p. 11.
[3]
The Hon. Dr Gillespie MP, House of Representatives Hansard,
1 June 2017, p. 11.
[4]
Commonwealth of Australia, Budget Measures: Budget Paper No. 2
2015–16, p. 111.
[5]
The Hon. Dr Gillespie MP, House of Representatives Hansard,
1 June 2017, p. 11.
[6]
Explanatory Memorandum, Industrial Chemicals (Notification and
Assessment) Amendment Bill 2017, p. 1.
[7]
Explanatory Memorandum, Industrial Chemicals (Notification and
Assessment) Amendment Bill 2017, p. 3.
[8]
Industrial Chemicals Charges (Customs) Bill 2017, cl. 7(1).
[9]
Joint Parliamentary Committee on Human Rights, Report No. 5 of 2017
(14 June 2017) p. 49.
[10]
Scrutiny of Bills Committee, Scrutiny Digest No. 6 of 2017 (14
June 2017) pp. 35–44.
[11]
Scrutiny of Bills Committee, Scrutiny Digest No. 6 of 2017 (14
June 2017) p. 35.
[12]
Scrutiny of Bills Committee, Scrutiny Digest No. 6 of 2017 (14
June 2017) p. 36.
[13]
Scrutiny of Bills Committee, Scrutiny Digest No. 6 of 2017 (14
June 2017) p. 37.
[14]
Scrutiny of Bills Committee, Scrutiny Digest No. 6 of 2017 (14
June 2017) p. 38.
[15]
Section 12(2) of the Legislation Act 2003 provides that a rule
cannot apply before it is registered to the extent that it would disadvantage a
person.
[16]
Scrutiny of Bills Committee, Scrutiny Digest No. 6 of 2017 (14
June 2017) pp. 38–39.
[17]
Scrutiny of Bills Committee, Scrutiny Digest No. 6 of 2017 (14
June 2017) pp. 40–43.
[18]
Scrutiny of Bills Committee, Ministerial responses, https://www.aph.gov.au/
Parliamentary_Business/Committees/Senate/Scrutiny_of_Bills/Ministerial_Responses
(accessed 31 July 2017).
[19]
The Bills were automatically referred to the Senate Community Affairs
Legislation Committee under a resolution of the Senate to refer time critical
bills see: Journals of the Senate, No. 40, 10 May 2017,
p. 1326. Journals of the Senate, No. 42, 13 June 2017,
p. 1383; Journals of the Senate, No. 44, 15 June 2017,
p. 1435.
Chapter 2 - Issues
[1]
House of Representatives Hansard, 1 June 2017, p. 12.
[2]
Department of Health, Submission 14, p. 4.
[3]
Mrs Gillian Shaw, Assistant Secretary, Department of Health, Committee
Hansard, 26 July 2017, p. 29.
[4]
See Industrial Chemicals Bill 2017, Pt 3.
[5]
See Industrial Chemicals Bill 2017, cl. 26.
[6]
Public Health Association of Australia, Submission 4, p. 6.
[7]
Explanatory Memorandum, Industrial Chemicals Bill 2017, pp. 24–25.
[8]
Dr Joe Hlubucek, Member, PHAA, Committee Hansard, 26 July 2017,
p. 3; Associate Professor Deborah Glass, Expert Member, Occupational and
Environmental Cancers Committee, Cancer Council Australia, Committee Hansard,
26 July 2017, p. 13.
[9]
Ms Renata Musolino, OHS Website and Information Organiser, Victorian
Trades Hall Council, Committee Hansard, 26 July 2017, p. 9.
[10]
Dr Sarah Rumble, Principal Advisor, NICNAS Reforms, National Industrial
Chemicals Notification and Assessment Scheme, Committee Hansard, 26 July
2017, p. 27.
[11]
Dr Rumble, Committee Hansard, 26 July 2017, p. 27.
[12]
Dr Rumble, Committee Hansard, 26 July 2017, p. 27.
[13]
Dr Rumble, Committee Hansard, 26 July 2017, p. 27.
[14]
Dr Rumble, Committee Hansard, 26 July 2017, p. 27.
[15]
Mr Craig Brock, Policy and Public Affairs Director, Accord Australia, Committee
Hansard, 26 July 2017, p. 20; Mr Bernard Lee, Director Policy and
Regulation, Chemistry Australia, Committee Hansard, 26 July 2017,
p. 21.
[16]
Haztech Environmental, Submission 1, p. 1;
National Toxics Network, Submission 13, [p. 3].
[17]
Haztech Environmental, Submission 1, p. 1; National Toxics
Network, Submission 13, [p. 3].
[18]
National Toxics Network, Submission 13, [p. 3].
[19]
Dr Rumble, Committee Hansard, 26 July 2017, p. 31.
[20]
Dr Rumble, Committee Hansard, 26 July 2017, p. 32.
[21]
Dr Rumble, answers to questions on notice, 26 July 2017 (received 2 August
2017).
[22]
Dr Rumble, answers to questions on notice, 26 July 2017 (received 2 August
2017).
[23]
PHAA, Submission 4, p. 8; Cancer Council Australia, Submission
6, [p. 2]; AMWU, Submission 8, pp. 3, 5; AMWU, Submission
8.1, [p. 2]; Dr Hlubucek, Committee Hansard, 26 July 2017,
p. 6; Ms Jo Immig, National Coordinator, National Toxics Network, Committee
Hansard, 26 July 2017, p. 6; Ms Musolino, Committee Hansard,
26 July 2017, p. 10.
[24]
Dr Hlubucek, Committee Hansard, 26 July 2017, p. 6.
[25]
Dr Hlubucek, Committee Hansard, 26 July 2017, p. 6.
[26]
Mr Terry Slevin, Chair, Occupational and Environmental Cancers Committee,
Cancer Council Australia, Committee Hansard, 26 July 2017, p. 11.
[27]
Dr Rumble, Committee Hansard, 26 July 2017, p. 34.
[28]
Dr Rumble, Committee Hansard, 26 July 2017, p. 34.
[29]
Dr Rumble, Committee Hansard, 26 July 2017, p. 34.
[30]
Dr Rumble, Committee Hansard, 26 July 2017, p. 35.
[31]
See Industrial Chemicals Bill 2017, cl. 180 (Rules), 26 (Exempted
introductions).
[32]
Cancer Council, Submission 6, [p. 2]; Australian Manufacturing
Workers' Union (AMWU), Submission 8, p. 4; National Toxics Network,
Submission 13, p. 5; Ms Musolino, Committee Hansard, 26 July
2017, p. 9; Mr Slevin, Committee Hansard, 26 July 2017, p. 10.
[33]
Mrs Shaw, Committee Hansard, 26 July 2017, p. 26.
[34]
Dr Rumble, Committee Hansard, 26 July 2017, p. 28.
[35]
Mrs Shaw, Committee Hansard, 26 July 2017, p. 26.
[36]
Explanatory Memorandum, Industrial Chemicals Bill 2017, p. 4.
[37]
See cl. 168. Clause 103 provides for the rule-making power.
[38]
Be Cruelty-Free Australia, Submission 15, [pp. 2–3];
RSPCA, Submission 16, [p. 1].
[39]
Be Cruelty-Free Australia, Submission 15, [pp. 2–3]; RSPCA, Submission
16, [p. 1]; Ms Hannah Stuart, Campaign Coordinator, Be
Cruelty-Free Australia, Humane Society International, Committee Hansard,
26 July 21017, p. 19; Dr Jed Goodfellow, Senior Policy Officer, RSPCA, Committee
Hansard, 26 July 2017, p. 19.
[40]
Accord, Submission 7, p. 4.
[41]
Dr Rumble, Committee Hansard, 26 July 2017, p. 33.
[42]
Dr Rumble, Committee Hansard, 26 July 2017, p. 33.
[43]
Dr Rumble, Committee Hansard, 26 July 2017, p. 34.
[44]
Mrs Shaw, Committee Hansard, 26 July 2017, p. 34.
[45]
Department of Health, Submission 14, pp. 5, 8–9; Mrs Shaw, Committee
Hansard, 26 July 2017, p. 34.
[46]
Cancer Council Australia, Submission 6, [p. 2]; AMWU, Submission
8, p. 4.
[47]
Dr Rumble, Committee Hansard, 26 July 2017, p. 35.
[48]
Mrs Shaw, Committee Hansard, 26 July 2017, p. 35.
Labor Senators' Additional Comments
[1]
Dr Sarah Rumble, Principal Advisor, NICNAS Reforms, National Industrial
Chemicals Notification and Assessment Scheme, Committee Hansard, 26 July
2017, p. 27.
[2]
AMWU, Submission 8.1, [p. 2].
Dissenting Report by the Australian Greens
[1]
Dr Joe Hlubucek, Member, Public Health Association of Australia, Committee
Hansard, 26 July 2017, pp. 2–3.
[2]
House of Representatives Hansard, 1 June 2017, pp. 11–13.
[3]
Dr Hlubucek, Committee Hansard, 26 July 2017, p. 3.
[4]
Ms Joanna Immig, National Toxics Network, Committee Hansard, 26
July 2017, p. 3.
[5]
Ms Immig, Committee Hansard, 26 July 2017, p. 5.
[6]
Prof Moore, Committee Hansard, 26 July 2017, p. 5.
[7]
Ms Musolino, Committee Hansard, 26 July 2017, p. 9.
[8]
Ms Musolino, Committee Hansard, 26 July 2017, p. 10.
[9]
Dr Hlubucek, Committee Hansard, 26 July 2017, p. 6.
[10]
Ms Musolino, Committee Hansard, 26 July 2017, p. 10.
[11]
Ms Musolino, Committee Hansard, 26 July 2017, p. 10.
[12]
Be Cruelty-Free Australia, Submission 15.
[13]
RSPCA, Submission 16.
[14]
Nexus Research, HRA Opinion Poll 2013 http://www.humaneresearch.org.au/_literature_
136286/Australians_say_no_to_animal_experiments (accessed 16 March 2014).
[15]
Accord, Submission 7, [p. 14].
[16]
Be Cruelty-Free Australia, Submission 15, p. 4.
[17]
World Trade Organisation, The General Agreement on Tariffs and Trade
(GATT 1947), Art. XX, http://www.wto.org/english/docs_e/legal_e/gatt47_02_e.htm
(accessed 8 August 2017).